| scholarly article | Q13442814 |
| P50 | author | Seung-Mo Hong | Q37392530 |
| Chang Ohk Sung | Q39689328 | ||
| Sung-Min Ahn | Q55136876 | ||
| Farhan Ul Haq | Q59708414 | ||
| Ju Hyun Shim | Q82226483 | ||
| Jihyun An | Q85583640 | ||
| P2093 | author name string | Jinho Shin | |
| Jene Choi | |||
| Kyu-Pyo Kim | |||
| Han Chu Lee | |||
| Eunsil Yu | |||
| Hyo Jeong Kang | |||
| Mi-Ju Kim | |||
| Soo-Heang Eo | |||
| Hui Jeong Jeong | |||
| P2860 | cites work | A mouse model of hepatocellular carcinoma: ectopic expression of fibroblast growth factor 19 in skeletal muscle of transgenic mice | Q24685118 |
| Clinical impact of copy number variation analysis using high-resolution microarray technologies: advantages, limitations and concerns | Q26859057 | ||
| First Selective Small Molecule Inhibitor of FGFR4 for the Treatment of Hepatocellular Carcinomas with an Activated FGFR4 Signaling Pathway | Q27698508 | ||
| Targeting FGFR4 inhibits hepatocellular carcinoma in preclinical mouse models | Q28729944 | ||
| Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update | Q33862786 | ||
| Fibroblast growth factor 19 expression correlates with tumor progression and poorer prognosis of hepatocellular carcinoma | Q34151946 | ||
| Expression of fibroblast growth factor 19 is associated with recurrence and poor prognosis of hepatocellular carcinoma | Q34330744 | ||
| Association of TP53 mutations with stem cell-like gene expression and survival of patients with hepatocellular carcinoma. | Q34672668 | ||
| Identification of a therapeutic strategy targeting amplified FGF19 in liver cancer by Oncogenomic screening | Q34701235 | ||
| Expression of hepatic Fibroblast Growth Factor 19 is enhanced in Primary Biliary Cirrhosis and correlates with severity of the disease | Q35979451 | ||
| Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets | Q36104399 | ||
| FGFR inhibitors: Effects on cancer cells, tumor microenvironment and whole-body homeostasis (Review). | Q36983860 | ||
| Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinoma | Q37138658 | ||
| Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma | Q37284612 | ||
| Genome-wide methylation analysis and epigenetic unmasking identify tumor suppressor genes in hepatocellular carcinoma. | Q37481324 | ||
| Identification of prognostic relevant chromosomal abnormalities in chronic lymphocytic leukemia using microarray-based genomic profiling | Q37528942 | ||
| Increased FGF19 copy number is frequently detected in hepatocellular carcinoma with a complete response after sorafenib treatment. | Q37580172 | ||
| Roles of FGF19 in liver metabolism. | Q37911126 | ||
| Liver cancer in 2013: Mutational landscape of HCC--the end of the beginning. | Q38176242 | ||
| New molecular therapies for hepatocellular carcinoma | Q38553305 | ||
| TERT promoter mutations in primary liver tumors | Q38580138 | ||
| Role of FGF19 induced FGFR4 activation in the regulation of glucose homeostasis | Q41974026 | ||
| Trans-ancestry mutational landscape of hepatocellular carcinoma genomes | Q42182370 | ||
| Genomic portrait of resectable hepatocellular carcinomas: implications of RB1 and FGF19 aberrations for patient stratification | Q42220401 | ||
| Targeting FGF19/FGFR4 Pathway: A Novel Therapeutic Strategy for Hepatocellular Carcinoma. | Q42343453 | ||
| DNA methylation-based prognosis and epidrivers in hepatocellular carcinoma. | Q51499838 | ||
| Targeting FGF19 inhibits tumor growth in colon cancer xenograft and FGF19 transgenic hepatocellular carcinoma models. | Q53331692 | ||
| P4510 | describes a project that uses | fluorescence in situ hybridization | Q1336182 |
| P433 | issue | 1 | |
| P304 | page(s) | 12-23 | |
| P577 | publication date | 2018-05-22 | |
| P1433 | published in | Liver cancer | Q26842090 |
| P1476 | title | Characterization of Hepatocellular Carcinoma Patients with FGF19 Amplification Assessed by Fluorescence in situ Hybridization: A Large Cohort Study | |
| P478 | volume | 8 |
Search more.